Radioligand Therapy
				Canadian Cancer Survivor Network
				Radioligands are at the forefront of innovation in prostate cancer care. These molecules, or ligands, have the remarkable ability to bind to specific receptors, exerting an effect on the cells where these receptors reside. The radioactive labelling of these ligands allows medical researchers to track their destination and monitor their behaviour within the body.